Literature DB >> 15329304

Brain activation patterns during a verbal fluency test-a functional MRI study in healthy volunteers and patients with schizophrenia.

Elisabeth M Weiss1, Alex Hofer, Stefan Golaszewski, Christian Siedentopf, Claudia Brinkhoff, Christian Kremser, Stefan Felber, W Wolfgang Fleischhacker.   

Abstract

FMRI was used to study cortical activation patterns in nine healthy male subjects and nine high-functioning male schizophrenia patients during a letter verbal fluency task. Both groups showed similar patterns of activation, however, in controls the activation was primarily in the left broca area, while for schizophrenia patients, it was more bilateral. These data indicate that high-functioning schizophrenia patients show a reduced language lateralization of the frontal cortex compared to healthy controls.

Entities:  

Mesh:

Year:  2004        PMID: 15329304     DOI: 10.1016/j.schres.2004.01.010

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  16 in total

1.  A functional MRI study: cerebral laterality for lexical-semantic processing and human voice perception.

Authors:  M Koeda; H Takahashi; N Yahata; K Asai; Y Okubo; H Tanaka
Journal:  AJNR Am J Neuroradiol       Date:  2006-08       Impact factor: 3.825

2.  Failure of language lateralization in schizophrenia patients: an ERP study on early linguistic components.

Authors:  Chiara Spironelli; Alessandro Angrilli; Luciano Stegagno
Journal:  J Psychiatry Neurosci       Date:  2008-05       Impact factor: 6.186

Review 3.  Imaging genetic liability to schizophrenia: systematic review of FMRI studies of patients' nonpsychotic relatives.

Authors:  Angus W MacDonald; Heidi W Thermenos; Deanna M Barch; Larry J Seidman
Journal:  Schizophr Bull       Date:  2008-06-12       Impact factor: 9.306

4.  Brain functional connectivity of male patients in remission after the first episode of schizophrenia.

Authors:  Tomas Kasparek; Radovan Prikryl; Jitka Rehulova; Radek Marecek; Michal Mikl; Hana Prikrylova; Jiri Vanicek; Eva Ceskova
Journal:  Hum Brain Mapp       Date:  2013-03       Impact factor: 5.038

5.  Aberrant transcriptomes and DNA methylomes define pathways that drive pathogenesis and loss of brain laterality/asymmetry in schizophrenia and bipolar disorder.

Authors:  Hamid M Abdolmaleky; Adam C Gower; Chen-Khuan Wong; Jiayi W Cox; Xiaoling Zhang; Arunthathi Thiagalingam; Rahim Shafa; Vadivelu Sivaraman; Jin-Rong Zhou; Sam Thiagalingam
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2018-11-23       Impact factor: 3.568

6.  Enuresis as a premorbid developmental marker of schizophrenia.

Authors:  Thomas M Hyde; Amy Deep-Soboslay; Bianca Iglesias; Joseph H Callicott; James M Gold; Andreas Meyer-Lindenberg; Robyn A Honea; Llewellyn B Bigelow; Michael F Egan; Esther M Emsellem; Daniel R Weinberger
Journal:  Brain       Date:  2008-07-31       Impact factor: 13.501

7.  Effect of retrieval effort and switching demand on fMRI activation during semantic word generation in schizophrenia.

Authors:  J D Ragland; S T Moelter; M T Bhati; J N Valdez; C G Kohler; S J Siegel; R C Gur; R E Gur
Journal:  Schizophr Res       Date:  2007-12-26       Impact factor: 4.939

8.  Meta-analysis of 41 functional neuroimaging studies of executive function in schizophrenia.

Authors:  Michael J Minzenberg; Angela R Laird; Sarah Thelen; Cameron S Carter; David C Glahn
Journal:  Arch Gen Psychiatry       Date:  2009-08

9.  Executive function network's white matter alterations relate to Parkinson's disease motor phenotype.

Authors:  Qinglu Yang; Shruti Nanivadekar; Paul A Taylor; Zulin Dou; Codrin I Lungu; Silvina G Horovitz
Journal:  Neurosci Lett       Date:  2020-11-05       Impact factor: 3.046

10.  Characterizing a neurodegenerative syndrome: primary progressive apraxia of speech.

Authors:  Keith A Josephs; Joseph R Duffy; Edythe A Strand; Mary M Machulda; Matthew L Senjem; Ankit V Master; Val J Lowe; Clifford R Jack; Jennifer L Whitwell
Journal:  Brain       Date:  2012-03-01       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.